Agenda

Accredited by

2023 Texas Lung Cancer Conference Agenda

Event Schedule

Welcome Day

Thursday, March 30, 2023

ACL Live, Keller Pfluger Gallery – Mezzanine Level, 2nd floor

6:00 PM - 9:00 PM

Welcome Reception & Fellows Poster Session

Day One

Friday, March 31, 2023

Breakfast Symposium (Non-CE)

W Hotel, Great Room

8:00 AM - 8:50 AM

Treatment Options For Resectable And PD-L1 <1% Metastatic NSCLC

Ani S. Balmanoukian, MD (The Angeles Clinic, a Cedars Sinai Affiliate)

Early-Stage NSCLC

ACL Live, General Session

9:10 AM

Optimizing Use of Neoadjuvant Immunotherapy in NSCLC

Tina Cascone, MD, PhD (MD Anderson Cancer Center)

9:25 AM

Can We Convert Unresectable to Resectable?

Brendon Stiles, MD (Montefiore Medical Center)

9:40 AM

Current Role of Adjuvant Immunotherapy in NSCLC

Jessica Donington, MD, MSCR (University of Chicago Medicine)

9:55 AM

Current Role of Adjuvant Targeted Therapy in NSCLC

Eric Nadler, MD, MPP (Texas Oncology)

10:10 AM

Best Practices in Unresectable NSCLC

David Spigel, MD (Sarah Cannon Research Institute)

10:25 AM

Q&A

10:40 AM

Close

Refreshments & Visit Exhibits (Non-CE)

ACL Live, Music Porch and W Hotel, Prefunction Hall

10:40 AM - 11:00 AM

Immunotherapy for Advanced NSCLC

ACL Live, General Session

11:00 AM

When is PD(L)1 Monotherapy Enough?

Shirish Gadgeel, MD (Henry Ford Health)

11:10 AM

Advantages of Chemo-Immunotherapy for NSCLC

Melissa Johnson, MD (Sarah Cannon Research Institute)

11:20 AM

The Evolving Role of Dual Checkpoint Inhibition

Hossein Borghaei, DO, MS (Fox Chase Cancer Center)

11:30 AM

Overcoming IO Resistance in NSCLC

Sheena Bhalla, MD (UT Southwestern Medical Center)

11:45 AM

Q&A

12:00 PM

Close

Lunch Symposium (Non-CE)

W Austin Hotel, Great Room

12:00 PM - 12:50 PM

Overcoming Barriers to Peri-operative Treatment in Early-Stage Lung Cancer

MODERATORS: Tina Cascone, MD, PhD (MD Anderson Cancer Center) & Brendon Stiles, MD (Montefiore Medical Center)

PANELISTS: Kristin Higgins, MD (Emory Winship Cancer Institute), Benjamin Levy, MD (Johns Hopkins University) & Jason Porter, MD (West Cancer Center & Research Institute)

SCLC and Mesothelioma

ACL Live, General Session

1:30 PM

Predicting the Future of Limited Stage SCLC

Kristin Higgins, MD (Emory Winship Cancer Institute)

1:40 PM

Best Practice for Extensive Stage SCLC

Lauren Byers, MD (MD Anderson Cancer Center)

1:55 PM

Managing Relapse for Advanced SCLC

Ticiana Leal, MD (Emory Winship Cancer Institute)

2:05 PM

Current Standards in Mesothelioma

Melina Marmarelis, MD, MSCE (University of Pennsylvania)

2:15 PM

Q&A

2:30 PM

Close

Refreshments & Visit Exhibits (Non-CE)

ACL Live, Music Porch and W Hotel, Prefunction Hall

2:30 pm - 2:50 pm

Digital Oncology

ACL Live, General Session

2:50 PM

Telehealth and Oncology: Natural Fit or Arranged Marriage?

Jack West, MD (City of Hope)

3:05 PM

Remote Tobacco Cessation

Randi Williams, PhD, MPH (Georgetown University)

3:20 PM

Mathematical Oncology

Alexander Anderson, PhD (Moffitt Cancer Center)

3:35 PM

The Future of Social Media and Oncology

Narjust Florez (Duma), MD (Dana-Farber Cancer Institute)

3:50 PM

Q&A

4:05 PM

Close

ACL Live, General Session

4:05 PM - 4:50 PM

Surprise Guest Speaker

Day Two

Saturday, April 1, 2023

Breakfast Symposium (Non-CE)

W Hotel, Great Room

8:00 AM - 8:50 AM

It’s Time to Move Forward for Patients With KRAS G12C-Mutated Locally Advanced or Metastatic NSCLC Following First-Line Therapy

Edgardo Santos, MD, FACP (Genesis Care US)

Targeted Therapy: EGFR, HER2

ACL Live, General Session

9:10 AM

Biomarkers: What is NGS?

Christine Lovly, MD, PhD (Vanderbilt University)

9:25 AM

First Line EGFR NSCLC: Is TKI enough?

Sandip Patel, MD (UC San Diego Health)

9:35 AM

Emerging Strategies for EGFR Exon 20

Julia Rotow, MD (Dana-Farber Cancer Institute)

9:50 AM

Overcoming EGFR TKI Resistance

Jonathan Riess, MD, MS (UC Davis Health)

10:05 AM

Targeting HER2 in NSCLC

Estelamari Rodriguez, MD, MPH (University of Miami)

10:15 AM

Refining EGFR Classification

John Heymach, MD, PhD (MD Anderson Cancer Center)

10:25 AM

Q&A

10:40 AM

Close

Refreshments & Visit Exhibits (Non-CE)

ACL Live, Music Porch and W Hotel, Prefunction Hall

10:40 AM - 11:00 AM

Targeted Therapy: Mutations: KRAS/BRAF/MET and ADCs

ACL Live, General Session

11:00 AM

Treating KRAS Mutant NSCLC

Ferdinandos Skoulidis, MD, PhD (MD Anderson Cancer Center)

11:15 AM

Best Practice for BRAF Mutant NSCLC

Ibiayi Dagogo-Jack, MD (Massachusetts General Hospital)

11:25 AM

Current and Future Practice for METex14

Paul Paik, MD (Memorial Sloan Kettering Cancer Center)

11:35 AM

Placing ADCs in the Treatment Algorithm

Joshua Reuss, MD (Georgetown University)

11:45 AM

Q&A

12:00 PM

Close

Lunch Symposium (Non-CE)

W Austin Hotel, Great Room

12:00 PM - 1:00 PM

How Is the Treatment of Patients With KRAS G12C-Mutated Advanced NSCLC Evolving?

Eric Nadler, MD, MPP (Texas Oncology)

Targeted Therapy: Fusions

ACL Live, General Session

1:30 PM

First Line Options for ALK and ROS1 NSCLC

Jason Porter, MD (West Cancer Center)

1:40 PM

Understanding and Overcoming Resistance in ALK/ROS1 NSCLC

Jessica Lin, MD, (Massachusetts General Hospital)

1:55 PM

Targeted Therapy for RET NSCLC

Edgardo Santos, MD, FACP (Genesis Care US)

2:05 PM

NTRK and NRG1 in NSCLC

Yasir Elamin, MD (MD Anderson Cancer Center)

2:15 PM

Q&A

2:30PM

Close

Refreshments & Visit Exhibits (Non-CE)

ACL Live, Music Porch and W Hotel, Prefunction Hall

2:30 pm - 2:50 pm

Refining Practice for the Coming Year

ACL Live, General Session

2:50 PM

Intersection of Community and Academic Oncology

R. Steven Paulson, MD (Texas Oncology)

3:00 PM

How to Incorporate Liquid Biopsy in Practice

Luis Raez, MD (Memorial Cancer Institute)

3:10 PM

Health Care Policy for Today's Oncologist

Debra Patt, MD, PhD (Texas Oncology)

3:20 PM

Q&A

ACL Live, General Session

3:30 PM

Debate Introduction: Is There A Role For CTLA-4 In MNSCLC

Keunchil Park, MD, PhD (MD Anderson Cancer Center)

3:30 PM

Debate: Is there a role for CTLA-4 in mNSCLC (FOR)

Balazs Halmos, MD (Montefiore Medical Center)

3:40 PM

Debate: Is there a role for CTLA-4 in mNSCLC (AGAINST)

Benjamin Levy, MD (Johns Hopkins University)

4:00 PM

Close

ACL Live, General Session

7:00 PM

Farewell Reception

Experience Austin, Texas

Come for the education.

Stay for the fun.

We look forward to hosting a unique conference at the historic venue, ACL Live at the Moody Theater in Austin, Texas.

Agenda

Accredited by

2023 Texas Lung Cancer Conference Agenda

Event Schedule

Welcome Day

Thursday, March 30, 2023

ACL Live, Keller Pfluger Gallery – Mezzanine Level, 2nd floor

6:00 PM - 9:00 PM

Welcome Reception & Fellows Poster Session

Day One

Friday, March 31, 2023

Breakfast Symposium (Non-CE)

W Hotel, Great Room

8:00 AM - 8:50 AM

Treatment Options For Resectable And PD-L1 <1% Metastatic NSCLC

Ani S. Balmanoukian, MD (The Angeles Clinic, a Cedars Sinai Affiliate)

Early-Stage NSCLC

ACL Live, General Session

9:10 AM

Optimizing Use of Neoadjuvant Immunotherapy in NSCLC

Tina Cascone, MD, PhD (MD Anderson Cancer Center)

9:25 AM

Can We Convert Unresectable to Resectable?

Brendon Stiles, MD (Montefiore Medical Center)

9:40 AM

Current Role of Adjuvant Immunotherapy in NSCLC

Jessica Donington, MD, MSCR (University of Chicago Medicine)

9:55 AM

Current Role of Adjuvant Targeted Therapy in NSCLC

Eric Nadler, MD, MPP (Texas Oncology)

10:10 AM

Best Practices in Unresectable NSCLC

David Spigel, MD (Sarah Cannon Research Institute)

10:25 AM

Q&A

10:40 AM

Close

Refreshments & Visit Exhibits (Non-CE)

ACL Live, Music Porch and W Hotel, Prefunction Hall

10:40 AM - 11:00 AM

Immunotherapy for Advanced NSCLC

ACL Live, General Session

11:00 AM

When is PD(L)1 Monotherapy Enough?

Shirish Gadgeel, MD (Henry Ford Health)

11:10 AM

Advantages of Chemo-Immunotherapy for NSCLC

Melissa Johnson, MD (Sarah Cannon Research Institute)

11:20 AM

The Evolving Role of Dual Checkpoint Inhibition

Hossein Borghaei, DO, MS (Fox Chase Cancer Center)

11:30 AM

Overcoming IO Resistance in NSCLC

Sheena Bhalla, MD (UT Southwestern Medical Center)

11:45 AM

Q&A

12:00 PM

Close

Lunch Symposium (Non-CE)

W Austin Hotel, Great Room

12:00 PM - 12:50 PM

Overcoming Barriers to Peri-operative Treatment in Early-Stage Lung Cancer

MODERATORS: Tina Cascone, MD, PhD (MD Anderson Cancer Center) & Brendon Stiles, MD (Montefiore Medical Center) PANELISTS: Kristin Higgins, MD (Emory Winship Cancer Institute), Benjamin Levy, MD (Johns Hopkins University) & Jason Porter, MD (West Cancer Center & Research Institute)

SCLC and Mesothelioma

ACL Live, General Session

1:30 PM

Predicting the Future of Limited Stage SCLC

Kristin Higgins, MD (Emory Winship Cancer Institute)

1:40 PM

Best Practice for Extensive Stage SCLC

Lauren Byers, MD (MD Anderson Cancer Center)

1:55 PM

Managing Relapse for Advanced SCLC

Ticiana Leal, MD (Emory Winship Cancer Institute)

2:05 PM

Current Standards in Mesothelioma

Melina Marmarelis, MD, MSCE (University of Pennsylvania)

2:15 PM

Q&A

2:30 PM

MODERATORS: Tina Cascone, MD, PhD (MD Anderson Cancer Center) & Brendon Stiles, MD (Montefiore Medical Center)

PANELISTS: Kristin Higgins, MD (Emory Winship Cancer Institute), Benjamin Levy, MD (Johns Hopkins University) & Jason Porter, MD (West Cancer Center & Research Institute)